Epiphany Dermatology — Lewisville, Texas

Epiphany Dermatology is a clinical research site located in Lewisville, Texas, United States 75056.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Epiphany Dermatology has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Cutaneous Squamous Cell Carcinoma (CSCC), Pyoderma Gangrenosum.

Sponsors: Regeneron Pharmaceuticals, Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lewisville

Browse all research sites in Texas · View every site in Lewisville

• Epic Clinical Research
• GSK Investigational Site
• Research Site
• Texas Oncology-Lewisville
• Lake Vista Cancer Center
• Prime Clinical Research - Lewisville
• Alliance Clinical Lewisville (Epic Clinical Research)
• Texas Oncology-Northeast Texas
• Research Site 29
• Novo Nordisk Investigational Site
• Travere Investigational Site
• Pri-Med Care

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Epiphany Dermatology?

Epiphany Dermatology has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Epiphany Dermatology conducted?

Epiphany Dermatology has 2 clinical trials on record, with 2 currently active. Their work covers Cutaneous Squamous Cell Carcinoma (CSCC), Pyoderma Gangrenosum.

Is Epiphany Dermatology accredited by Crixeo Clinical Trials?

Epiphany Dermatology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Epiphany Dermatology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.